Centessa Pharmaceuticals Funding & Investors
Cambridge, MA
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
centessa.comTotal Amount Raised: $875,000,000
Centessa Pharmaceuticals Funding Rounds
Post Ipo Equity
$225,000,000
Post Ipo Equity
$100,000,000
Post Ipo Debt
$300,000,000
Post Ipo Debt Investors
Oberland CapitalSeries A
$250,000,000
Series A Investors
General AtlanticHenderson Global InvestorsVida VenturesEcoR1 CapitalLifeSci Venture PartnersSamsara BioCapitalT. Rowe PriceWellington ManagementBoxer CapitalCormorant Asset ManagementBvf PartnersVenrock Healthcare Capital PartnersLogos CapitalFranklin Resources, Inc.IP GroupIPO
Unknown
Funding info provided by Diffbot.